title: Factors affecting surgical management following neoadjuvant therapy in patients with primary HER2-positive breast cancer: results from the NeoALTTO phase III trial.
authors.affiliation: Department of Medical Oncology, Istituto Europeo di Oncologia, Milan, Italy. Electronic address: carmen.criscitiello@ieo.it.
authors.forename: C
authors.initials: C
authors.lastname: Criscitiello
authors.affiliation: BrEAST Data Centre and Department of Medicine, Clinical Oncology, Brussels, Belgium.
authors.forename: H A
authors.initials: HA
authors.lastname: Azim
authors.affiliation: BrEAST Data Centre and Department of Medicine, Clinical Oncology, Brussels, Belgium.
authors.forename: E
authors.initials: E
authors.lastname: de Azambuja
authors.affiliation: Breast Surgical Onclogy Unit, Universitario Vall D'Hebron, Barcelona, Spain.
authors.forename: I T
authors.initials: IT
authors.lastname: Rubio
mesh_terms: D001943:Breast Neoplasms / Q000188:drug therapy* / Q000601:surgery*; D005260:Female; D006801:Humans; D015412:Mastectomy, Segmental; D020360:Neoadjuvant Therapy; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000378:metabolism*
chemical_list: D018719:Erb-b2 Receptor Tyrosine Kinases